Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for severe COVID-19.

Date publication

janvier 2023

Journal

BMC pulmonary medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie

Tous les auteurs :
Noureddine S, Roux-Claudé P, Laurent L, Ritter O, Dolla P, Karaer S, Claudé F, Eberst G, Westeel V, Barnig C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36635717

Résumé

Cardiopulmonary exercise testing (CPET) is an important clinical tool that provides a global assessment of the respiratory, circulatory and metabolic responses to exercise which are not adequately reflected through the measurement of individual organ system function at rest. In the context of critical COVID-19, CPET is an ideal approach for assessing long term sequelae.

Mots clés

Acute respiratory distress syndrome, COVID-19, Cardiopulmonary exercise testing, Peak oxygen consumption, Pulmonary vascular disease, SARS-CoV-2

Référence

BMC Pulm Med. 2023 01 12;23(1):13